Cellular Signalling Networks in High Altitude Pulmonary Hypertension: From Canonical Pathways to Emerging Targets
Cell Proliferation · 2026
DOI: 10.1111/cpr.70179 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Proliferation, 2026. Verfasst von Sheng Ding und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medical College & Affiliated Hospital, Chengdu University, Chengdu, P. R. China. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Signal Transduction, Altitude Sickness. Die Arbeit nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Sichuan Province, National Natural Science Foundation of China, Chengdu University.
Abstract (Originalsprache)
High altitude pulmonary hypertension (HAPH) is a complex disease featured by hypoxia‐induced pulmonary vasoconstriction and remodelling of small pulmonary arterioles, which could lead to increased pulmonary pressures and right ventricular hypertrophy and eventually result in heart failure. The temporal trajectory of HAPH progression can be divided into three overlapping phases: hypoxic pulmonary arterioles vasoconstriction, hypoxic pulmonary arterioles remodelling and even right heart failure. Each phase is governed by distinct molecular engines and cellular effectors that translate hypoxia physiological adaption into irreversible cardiopulmonary dysfunction. This review describes the intricate cellular signalling networks involved in the pathogenesis of HAPH, integrating canonical pathways such as HIF, MAPK and BMP with emerging targets like Wnt/β‐catenin, Notch, Hippo‐YAP and IL‐6. Inhibiting the HIF signalling pathway, modulating the MAPK pathway and suppressing the BMP, Wnt/β‐catenin, Notch, Hippo‐YAP and IL‐6 pathways have shown potential in reducing vascular remodelling and right ventricular dysfunction. Despite encouraging progress, the clinical translation remains constrained by a lack of deeper understanding of the signalling networks in HAPH. A comprehensive understanding of these signalling pathways in HAPH may yield critical insights into the disease's pathogenesis and facilitate the development of targeted intervention strategies. Future research should focus on elucidating the molecular mechanisms underlying these pathways, exploring genetic and environmental interactions, validating intervention targets, developing biomarkers, utilising systems biology approaches and conducting clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Medical College & Affiliated Hospital, Chengdu University, Chengdu, P. R. China.
- Medical College, Qinghai University, Xining, P. R. China.
- College of Pharmacy, Chengdu University, Chengdu, P. R. China.
- National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, P. R. China.
ORCID-Profile: Sheng Ding
Förderung
- Natural Science Foundation of Sichuan Province
- National Natural Science Foundation of China
- Chengdu University
- Natural Science Foundation of Tibet Autonomous Region
Zitieren
APA
Ding, S., Chen, J., Li, Z., Yu, Y., Wang, W., Liao, Y., Yang, J., Lu, D., & Fan, Y. (2026). Cellular Signalling Networks in High Altitude Pulmonary Hypertension: From Canonical Pathways to Emerging Targets. Cell Proliferation. https://doi.org/10.1111/cpr.70179
Vancouver
Ding S, Chen J, Li Z, Yu Y, Wang W, Liao Y, et al. Cellular Signalling Networks in High Altitude Pulmonary Hypertension: From Canonical Pathways to Emerging Targets. Cell Proliferation. 2026. doi:10.1111/cpr.70179
BibTeX
@article{Ding2026,
author = {Ding, Sheng and Chen, Ju and Li, Zhaoyang and Yu, Yang and Wang, Weijie and Liao, Yan and Yang, Jin and Lu, Dianxiang and Fan, Yujiang},
title = {Cellular Signalling Networks in High Altitude Pulmonary Hypertension: From Canonical Pathways to Emerging Targets},
journal = {Cell Proliferation},
year = {2026},
doi = {10.1111/cpr.70179}
}
EUVIMED